Bright Minds Biosciences (DRUG) announced the expansion of its Scientific Advisory Board to include five distinguished experts in epilepsy research: Dennis Dlugos, MD, MSCE; Jacqueline French, MD; Terrence O’Brien, MD; Jo Sourbron, MD, PhD, MPharm; Joseph Sullivan, MD. Dennis J. Dlugos, MD, MSCE, is Professor of Neurology and Pediatrics at the University of Pennsylvania; and Director, Pediatric Epilepsy Program at Children’s Hospital of Philadelphia. Jacqueline French, MD, is a professor of Neurology in the Comprehensive Epilepsy Center at NYU Grossman School of Medicine and Founder/Director of the Epilepsy Study Consortium. Terence J. O’Brien, MD, is Chair of Medicine and Head, The School of Translational Medicine, Monash University and Program Director, Alfred Brain and Deputy Director of Research, Alfred Health. Dr. Jo Sourbron, MD, PhD, MPharm, is a physician scientist with a clinical practice at the University Hospitals of Ghent and a postdoctoral researcher at the University of Leuven. Joseph Sullivan, MD, is a professor of neurology and pediatrics at the University of California, San Francisco and director of the UCSF Pediatric Epilepsy Center of Excellence at Benioff Children’s Hospital.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DRUG:
- Bright Minds Biosciences to Engage in Key Healthcare Conferences
- Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential
- Bright Minds Biosciences Shows Financial Improvement in Latest Report
- Bright Minds Biosciences initiated with an Overweight at Piper Sandler
- Bright Minds Biosciences initiated with an Overweight at Cantor Fitzgerald